Charles Schwab’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.95M | Buy |
299,404
+55,425
| +23% | +$1.1M | ﹤0.01% | 2258 |
|
|
2025
Q1 | $4.12M | Buy |
243,979
+33,768
| +16% | +$571K | ﹤0.01% | 2349 |
|
|
2024
Q4 | $3.88M | Sell |
210,211
-34,977
| -14% | -$646K | ﹤0.01% | 2455 |
|
|
2024
Q3 | $5.33M | Sell |
245,188
-24,068
| -9% | -$523K | ﹤0.01% | 2346 |
|
|
2024
Q2 | $5.28M | Sell |
269,256
-25,684
| -9% | -$504K | ﹤0.01% | 2340 |
|
|
2024
Q1 | $6.4M | Buy |
294,940
+27,627
| +10% | +$600K | ﹤0.01% | 2196 |
|
|
2023
Q4 | $7.73M | Buy |
267,313
+33,141
| +14% | +$958K | ﹤0.01% | 2123 |
|
|
2023
Q3 | $6.26M | Buy |
234,172
+32,875
| +16% | +$879K | ﹤0.01% | 2148 |
|
|
2023
Q2 | $7.45M | Buy |
201,297
+21,691
| +12% | +$803K | ﹤0.01% | 2050 |
|
|
2023
Q1 | $5.61M | Buy |
179,606
+30,830
| +21% | +$963K | ﹤0.01% | 2150 |
|
|
2022
Q4 | $4.43M | Sell |
148,776
-1,443
| -1% | -$43K | ﹤0.01% | 2278 |
|
|
2022
Q3 | $5.73M | Buy |
150,219
+6,066
| +4% | +$231K | ﹤0.01% | 2142 |
|
|
2022
Q2 | $7.86M | Buy |
144,153
+129
| +0.1% | +$7.04K | ﹤0.01% | 1962 |
|
|
2022
Q1 | $8.99M | Buy |
144,024
+3,771
| +3% | +$235K | ﹤0.01% | 2012 |
|
|
2021
Q4 | $14.1M | Sell |
140,253
-6,969
| -5% | -$701K | ﹤0.01% | 1809 |
|
|
2021
Q3 | $13.2M | Buy |
147,222
+19,795
| +16% | +$1.78M | ﹤0.01% | 1846 |
|
|
2021
Q2 | $11.8M | Buy |
127,427
+16,044
| +14% | +$1.48M | ﹤0.01% | 1913 |
|
|
2021
Q1 | $10.8M | Buy |
111,383
+24,441
| +28% | +$2.36M | ﹤0.01% | 1918 |
|
|
2020
Q4 | $4.53M | Buy |
86,942
+14,214
| +20% | +$741K | ﹤0.01% | 2267 |
|
|
2020
Q3 | $2.91M | Buy |
72,728
+46,385
| +176% | +$1.86M | ﹤0.01% | 2347 |
|
|
2020
Q2 | $422K | Buy |
+26,343
| New | +$422K | ﹤0.01% | 2899 |
|